Category: Ophthalmology
May 13, 2025
MHRA approves teprotumumab as the first UK treatment for adults for TED
MHRA approves teprotumumab as the first UK treatment for adults for TED
TED is an autoimmune condition where the immune system attacks the muscles and fat around the eyes.
Read More..January 16, 2024
Prevent and Protect Training Initiative funded training on Ophthalmology
Prevent and Protect Training Initiative funded training on Ophthalmology
Supporting allied healthcare professionals CPD-accredited courses in ophthalmology
Read More..
